Evotec SE is a Germany-based drug discovery alliance and development partnership company. The Company focuses mainly on product approaches with a number of pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, womenâ€™s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.